Frontlight ResearchEarly access
Trial site
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C (Site 6007)
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 32 trials
- Status
- Recruiting2 trials
- Lead sponsor
- Merck Sharp & Dohme LLC2 trials
Running trials
Recruiting
Recruiting
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026